<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01969630</url>
  </required_header>
  <id_info>
    <org_study_id>Arezzo011</org_study_id>
    <nct_id>NCT01969630</nct_id>
  </id_info>
  <brief_title>Paclitaxel-eluting Balloon Angioplasty With Provisional Use of Nitinol Stent Versus Systematic Implantation of Paclitaxel-eluting Stent for the Treatment of Femoropopliteal de Novo Lesions</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale San Donato</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale San Donato</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine in patients with symptomatic femoropopliteal lesions whether percutaneous
      revascularization with paclitaxel-eluting balloon angioplasty (PEB) and provisional nitinol
      stent is superior with respect to the 12-month incidence of restenosis compared to treatment
      with systematic paclitaxel-eluting stent (PES) angioplasty
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2013</start_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>angiographic binary restenosis</measure>
    <time_frame>12 months</time_frame>
    <description>incidence of binary restenosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite of all cause mortality, major amputation and target lesion revascularization.</measure>
    <time_frame>12 months</time_frame>
    <description>incidence of composite endpoint of all cause mortality, major amputation and target lesion revascularization.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Peripheral Artery Disease</condition>
  <arm_group>
    <arm_group_label>PEB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PEB angioplasty plus provisional nitinol stent implantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PES</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Systematic PES angioplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PEB</intervention_name>
    <description>Paclitaxel eluting balloon angioplasty plus provisional nitinol stent implantation</description>
    <arm_group_label>PEB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PES</intervention_name>
    <description>Systematic Paclitaxel eluting stent angioplasty</description>
    <arm_group_label>PES</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  intermittent claudication or critical limb ischemia

          -  de novo stenosis â‰¥ 50% or occlusion of at least 40 mm in length located in
             femoropopliteal arteries

          -  presence of a clear healthy segment between the lesion in superficial femoral and
             common femoral artery and between popliteal and tibioperoneal trunk

          -  presence of at least 1 patent tibial vessel with distal run-off (below-the-knee artery
             was considered patent if free from obstructive lesions determining angiographic
             stenosis &gt;70%)

        Exclusion Criteria:

          -  life expectancy &lt;1 year

          -  contraindication for combined antiplatelet therapy or known allergy to nickel or
             paclitaxel

          -  need for major amputation (MA) at the time of enrolment

          -  Failure to recanalize intended below-the-knee arteries in CLI patients at risk of
             major amputation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cardiovascular Department, Ospedale S.Donato</name>
      <address>
        <city>Arezzo</city>
        <state>AR</state>
        <zip>52100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Liistro, MD</last_name>
      <email>francescoliistro@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Leonardo Bolognese, MD, FESC</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giovanni Falsini, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paolo Angioli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kenneth Ducci, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francesco Liistro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simone Grotti, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Italo Porto, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2013</study_first_submitted>
  <study_first_submitted_qc>October 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 25, 2013</study_first_posted>
  <last_update_submitted>October 21, 2013</last_update_submitted>
  <last_update_submitted_qc>October 21, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale San Donato</investigator_affiliation>
    <investigator_full_name>Leonardo Bolognese, MD</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>femoropopliteal lesions</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
    <mesh_term>Albumin-Bound Paclitaxel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

